Tengjun Biotechnology Corp
Tengjun Biotechnology Corp., through its subsidiaries, engages in producing, packaging, distributing, and marketing featured dandelion teas and water purifiers in the People's Republic of China. It offers black and green dandelion teas; and household water purifiers. The company was founded in 2010 and is headquartered in Jining, China.
Tengjun Biotechnology Corp (TJBH) - Net Assets
Latest net assets as of June 2023: $15.26 Million USD
Based on the latest financial reports, Tengjun Biotechnology Corp (TJBH) has net assets worth $15.26 Million USD as of June 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($438.96 Million) and total liabilities ($423.70 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $15.26 Million |
| % of Total Assets | 3.48% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Tengjun Biotechnology Corp - Net Assets Trend (2015–2022)
This chart illustrates how Tengjun Biotechnology Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Tengjun Biotechnology Corp (2015–2022)
The table below shows the annual net assets of Tengjun Biotechnology Corp from 2015 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $14.97 Million | +755.04% |
| 2021-12-31 | $-2.29 Million | -709.10% |
| 2020-12-31 | $-282.50K | -1.02% |
| 2019-12-31 | $-279.64K | -14.07% |
| 2018-12-31 | $-245.15K | -13.89% |
| 2017-12-31 | $-215.25K | -6.52% |
| 2016-12-31 | $-202.07K | -29.29% |
| 2015-12-31 | $-156.29K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Tengjun Biotechnology Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 846634300.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $8.16 Million | 56.44% |
| Common Stock | $96.31K | 0.67% |
| Other Components | $6.20 Million | 42.89% |
| Total Equity | $14.46 Million | 100.00% |
Tengjun Biotechnology Corp Competitors by Market Cap
The table below lists competitors of Tengjun Biotechnology Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jaeyoung Solutec Co. Ltd
KQ:049630
|
$149.45 Million |
|
Shanghai Smart Control Co. Ltd.
SHE:001266
|
$149.46 Million |
|
Finwise Bancorp
NASDAQ:FINW
|
$149.49 Million |
|
Heritage Foods Limited
NSE:HERITGFOOD
|
$149.49 Million |
|
EXPLOS. PROD. CHIM.EO 31
F:9Z50
|
$149.41 Million |
|
OP Bancorp
NASDAQ:OPBK
|
$149.38 Million |
|
Awfis Space Solutions Ltd
NSE:AWFIS
|
$149.36 Million |
|
Commerce.com, Inc.
NASDAQ:CMRC
|
$149.33 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Tengjun Biotechnology Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from -2,191,431 to 14,455,397, a change of 16,646,828.
- Net income of 11,346,841 contributed positively to equity growth.
- Share repurchases of 5,551,828 reduced equity.
- New share issuances of 5,551,828 increased equity.
- Other factors increased equity by 5,299,987.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $11.35 Million | +78.5% |
| Share Repurchases | $5.55 Million | -38.41% |
| Share Issuances | $5.55 Million | +38.41% |
| Other Changes | $5.30 Million | +36.66% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Tengjun Biotechnology Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 13.33x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | $-0.01 | $2.00 | x |
| 2018-12-31 | $-0.01 | $2.00 | x |
| 2019-12-31 | $-0.01 | $2.00 | x |
| 2020-12-31 | $-0.01 | $2.00 | x |
| 2021-12-31 | $-0.03 | $2.00 | x |
| 2022-12-31 | $0.15 | $2.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Tengjun Biotechnology Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 78.50%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.56%
- • Asset Turnover: 2.56x
- • Equity Multiplier: 4.06x
- Recent ROE (78.50%) is above the historical average (9.81%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-59.08K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-40.46K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-26.71K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-23.29K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-31.90K |
| 2020 | 0.00% | -18575.17% | 0.03x | 0.00x | $-25.62K |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-528.38K |
| 2022 | 78.50% | 7.56% | 2.56x | 4.06x | $9.90 Million |
Industry Comparison
This section compares Tengjun Biotechnology Corp's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $5,681,533,529
- Average return on equity (ROE) among peers: 0.04%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Tengjun Biotechnology Corp (TJBH) | $15.26 Million | 0.00% | 27.76x | $149.42 Million |
| Above Food Ingredients Inc. Common Stock (ABVE) | $30.90K | -3.31% | 7.66x | $18.76 Million |
| The a2 Milk Company Limited (ACOPF) | $7.27 Million | -30.19% | 0.14x | $3.91 Billion |
| Ayujoy Herbals Ltd (AJOY) | $22.20 Million | 29.29% | 0.00x | $95.71 |
| Alfa S.A.B. de C.V (ALFFF) | $53.35 Billion | 7.36% | 3.80x | $2.16 Billion |
| Amincor Inc (AMNCB) | $34.44 Million | -63.76% | 0.81x | $2.24K |
| Armanino Foods New (AMNF) | $21.40 Million | 30.30% | 0.33x | $72.33K |
| Amira Nature Foods Ltd (ANFIF) | $303.22 Million | 8.27% | 0.89x | $128.79 |
| AAK AB (publ.) (ARHUF) | $2.44 Billion | 12.85% | 2.63x | $5.07 Billion |
| Artisan Consumer Goods Inc (ARRT) | $-326.75K | 0.00% | 0.00x | $279.39K |
| ARYZTA AG (ARZTF) | $632.10 Million | 9.58% | 2.04x | $53.13 Million |